CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

PHASE4CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Asthma
Interventions
DRUG

Salmeterol/fluticasone propionate or formoterol/budesonide

Trial Locations (106)

6

GSK Investigational Site, Dublin

8

GSK Investigational Site, Dublin

22

GSK Investigational Site, Dublin

24

GSK Investigational Site, Tallaght, Dublin

1001

GSK Investigational Site, Auckland

1606

GSK Investigational Site, Sofia

1701

GSK Investigational Site, Auckland

2041

GSK Investigational Site, Balmain

3300

GSK Investigational Site, Tienen

3945

GSK Investigational Site, Oostham

3970

GSK Investigational Site, Leopoldsburg

3980

GSK Investigational Site, Tessenderlo

4021

GSK Investigational Site, Kippa-Ring

4077

GSK Investigational Site, Brisbane

5065

GSK Investigational Site, Toorak Gardens

6060

GSK Investigational Site, Gilly

7000

GSK Investigational Site, Rousse

7301

GSK Investigational Site, Hornu

7800

GSK Investigational Site, Ath

8001

GSK Investigational Site, Christchurch Hospital

9010

GSK Investigational Site, Varna

9100

GSK Investigational Site, Skopje

9300

GSK Investigational Site, Aalst

10120

GSK Investigational Site, Tallinn

10178

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

13086

GSK Investigational Site, Berlin

13187

GSK Investigational Site, Berlin

13353

GSK Investigational Site, Berlin

13419

GSK Investigational Site, Tallinn

13597

GSK Investigational Site, Berlin

14469

GSK Investigational Site, Potsdam

15006

GSK Investigational Site, A Coruña

15850

GSK Investigational Site, Lahti

27004

GSK Investigational Site, Lugo

28006

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28922

GSK Investigational Site, Alcorcón

29400

GSK Investigational Site, Málaga

33520

GSK Investigational Site, Tampere

35020

GSK Investigational Site, Las Palmas

46017

GSK Investigational Site, Valencia

48960

GSK Investigational Site, Galdakano

51014

GSK Investigational Site, Tartu

68600

GSK Investigational Site, Jakobstad

76646

GSK Investigational Site, Bruchsal

77933

GSK Investigational Site, Lahr

78300

GSK Investigational Site, Varkaus

80100

GSK Investigational Site, Joensuu

81677

GSK Investigational Site, Munich

86150

GSK Investigational Site, Augsburg

91052

GSK Investigational Site, Erlangen

92100

GSK Investigational Site, Raahe

A-4020

GSK Investigational Site, Linz

A-1030

GSK Investigational Site, Vienna

A-1120

GSK Investigational Site, Vienna

A-1210

GSK Investigational Site, Vienna

Unknown

GSK Investigational Site, Plovdiv

GSK Investigational Site, Blackpool, Cork

GSK Investigational Site, Dublin

GSK Investigational Site, Galway

GSK Investigational Site, Kilkenny

GSK Investigational Site, Lifford

T2N 4N1

GSK Investigational Site, Calgary

V2X 2L5

GSK Investigational Site, Maple Ridge

V5Z 3J5

GSK Investigational Site, Vancouver

R2H 2A6

GSK Investigational Site, Winnipeg

E2M 3W5

GSK Investigational Site, Saint John

L6Y 2E6

GSK Investigational Site, Brampton

L8N 3Z5

GSK Investigational Site, Hamilton

L5A 1N1

GSK Investigational Site, Mississauga

L5M 2V8

GSK Investigational Site, Mississauga

K9J 7B3

GSK Investigational Site, Peterborough

H3G 1A4

GSK Investigational Site, Montreal

H4J 1C5

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Sainte-Foy

31 025

GSK Investigational Site, Kohtal-Jdrve

LV 4000

GSK Investigational Site, Limbaži

LV 1002

GSK Investigational Site, Riga

LV 1035

GSK Investigational Site, Riga

LV 4201

GSK Investigational Site, Valmiera

5211 NL

GSK Investigational Site, 's-Hertogenbosch

7609 PP

GSK Investigational Site, Almelo

2121 BB

GSK Investigational Site, Bennebroek

5623 EJ

GSK Investigational Site, Eindhoven

4191 AH

GSK Investigational Site, Geldermalsen

6419 PC

GSK Investigational Site, Heerlen

5707 HA

GSK Investigational Site, Helmond

7581 BV

GSK Investigational Site, Losser

4921 BC

GSK Investigational Site, Made

3015 GD

GSK Investigational Site, Rotterdam

3207 NB

GSK Investigational Site, Spijkenisse

2584 CX

GSK Investigational Site, Utrecht

6367 ED

GSK Investigational Site, Voerendaal

08003

GSK Investigational Site, Barcelona

08221

GSK Investigational Site, Barcelona

CB3 9HS

GSK Investigational Site, Cambridge

CB10 1EJ

GSK Investigational Site, Saffron Walden

CF63 4HP

GSK Investigational Site, Barry

CF14 9BB

GSK Investigational Site, Cardiff

CF23 5SY

GSK Investigational Site, Cardiff

FY1 6JW

GSK Investigational Site, Blackpool

FY4 3AD

GSK Investigational Site, Blackpool

M23 9GP

GSK Investigational Site, Manchester

FY7 6HD

GSK Investigational Site, Fleetwood

FY7 7DG

GSK Investigational Site, Fleetwood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00479739 - CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. | Biotech Hunter | Biotech Hunter